BofA Securities analyst Alec Stranahan maintains $Eli Lilly and Co (LLY.US)$ with a buy rating, and maintains the target price at $1,100.
According to TipRanks data, the analyst has a success rate of 48.3% and a total average return of -3.2% over the past year.
Furthermore, according to the comprehensive report, the opinions of $Eli Lilly and Co (LLY.US)$'s main analysts recently are as follows:
Eli Lilly's recent quarter revealed uneven results for Mounjaro and Zepbound. However, the fluctuation was attributed to inventory dynamics rather than supply or demand issues. Despite a slight reduction in the projections for Mounjaro and Zepbound, the overall outlook for Eli Lilly remains positive, even considering the third-quarter hiccup.
Following the Q3 report, there's a recognition that substantial efforts are necessary for Q4 due to the $1B tirzepatide shortfall. This situation is compounded by the fluctuations in channel inventories and the shift of direct-to-consumer activities to the middle of the quarter.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
美银证券分析师Alec Stranahan维持$礼来 (LLY.US)$买入评级，维持目标价1,100美元。
根据TipRanks数据显示，该分析师近一年总胜率为48.3%，总平均回报率为-3.2%。
此外，综合报道，$礼来 (LLY.US)$近期主要分析师观点如下：
Eli Lilly最近的一个季度显示，Mounjaro和Zepbound的表现不稳定。然而，这种波动被归因于库存动态，而不是供应或需求问题。尽管对Mounjaro和Zepbound的预测略有减少，但对Eli Lilly的整体前景仍然积极，即使考虑到第三季度的小问题。
根据第三季度报告，人们认识到由于10亿美元的Tirzepatide缺口，Q4需要做出大量努力。这种情况加剧了渠道库存的波动，以及直接面向消费者活动转移到季度中期的问题。
提示:
TipRanks为独立第三方，提供金融分析师的分析数据，并计算分析师推荐的平均回报率和胜率。提供的信息并非投资建议，仅供参考。本文不对评级数据和报告的完整性与准确性做出认可、声明或保证。
TipRanks提供每位分析师的星级，分析师星级代表分析师所有推荐的过往表现，通过分析师的总胜率和平均回报率综合计算得出，星星越多，则该分析师过往表现越优异，最高为5颗星。
分析师总胜率为近一年分析师的评级成功次数占总评级次数的比率。评级的成功与否，取决于TipRanks的虚拟投资组合是否从该股票中产生正回报。
总平均回报率为基于分析师的初始评级创建虚拟投资组合，并根据评级变化对组合进行调整，在近一年中该投资组合所获得的回报率。
